Depressive and anxiety disorders in epilepsy: Do they differ in their potential to worsen common antiepileptic drug-related adverse events?

Epilepsia

Volumn 53, Issue 6, 2012, Pages 1104-1108

  Kanner, Andres M ^a   Barry, John J ^b   Gilliam, Frank ^c   Hermann, Bruce ^d   Meador, Kimford J ^e  

^a RUSH MEDICAL COLLEGE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant medication; Generalized anxiety disorder; Pharmacoresistant epilepsy

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DSM-IV-TR; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SCORING SYSTEM; STRUCTURED INTERVIEW; SUBSYNDROMIC DEPRESSIVE EPISODE; UNSPECIFIED SIDE EFFECT;

EID: 85027944469     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03488.x     Document Type: Article

References (14)

1. American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders IV-TR. American Psychiatric Press, Washington DC.
2. Baker GA, Middleton A, Jacoby A,. (1994) Initial development, reliability, and validity of a patient-based adverse event scale. Epilepsia 35 (Suppl. 7): 80.
3. Beck AT,. (1987) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
4. Cramer JA, Blum M, Reed M, Fanning K,; Epilepsy Impact Project. (2003) The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 4: 515-521.
5. Ettinger AB, Reed M, Cramer J,. (2004) Depression and co-morbidity in community-based patients with epilepsy or asthma. Neurology 63: 1008-1014.
6. First MB, Spitzer RL, Gibbon ML, Williams JBW,. (1995) Structured clinical interview for DSM IV Axis I disorders. NY State Psychiatric Institute Biometrics Research, New York.
7. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H,. (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62: 23-27.
8. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM,. (2006) Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 5: 399-405.
9. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B,. (2007) Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 146: 317-325.
10. Perucca P, Jacoby A, Marson AG, Baker GA, Lane S, Benn EK, Thurman DJ, Hauser WA, Gilliam FG, Hesdorffer DC,. (2011) Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 76: 273-279.
11. Sheehan BV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC,. (1998) The Mini International Neuropsychiatric Interview (MINI): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl. 20): 22-33.
12. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S,. (2007) Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48: 2336-2344.
13. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ,. (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106: 203-214.
14. Zigmond AS, Snaith RP,. (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.